1.
Campylobacteriosis: the role of poultry meat
by Skarp, C.P.A
Clinical microbiology and infection, 2016, Vol.22 (2), p.103-109
2.
Composition of human faecal microbiota in resistance to Campylobacter infection
by Kampmann, C
Clinical microbiology and infection, 2016, Vol.22 (1), p.61.e1-61.e8
3.
Lipooligosaccharide locus class of Campylobacter jejuni: sialylation is not needed for invasive infection
by Ellström, P
Clinical microbiology and infection, 2014, Vol.20 (6), p.524-529
4.
Accessory genetic content in Campylobacter jejuni ST21CC isolates from feces and blood
by Skarp, C.P.A
International journal of medical microbiology, 2017, Vol.307 (4), p.233-240
5.
Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy – a placebo‐controlled, double‐blind randomized pilot study
by Myllyluoma, E.
Alimentary pharmacology & therapeutics, 2005, Vol.21 (10), p.1263-1272
6.
Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates
by Feodoroff, F.B.L
Clinical microbiology and infection, 2009, Vol.15 (2), p.188-192
7.
An outbreak of gastroenteritis from a non-chlorinated community water supply
by Kuusi, M
Journal of epidemiology and community health (1979), 2004, Vol.58 (4), p.273-277
8.
Evidence that cagA+Helicobacter pylori strains are disappearing more rapidly than cagA− strains
by Perez-Perez, G I
Gut, 2002, Vol.50 (3), p.295-298
9.
Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy
by Oksanen, A
Gut, 2000, Vol.46 (4), p.460-463
10.
Primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Finnish population
by Koivisto, T. T.
Alimentary pharmacology & therapeutics, 2004, Vol.19 (9), p.1009-1017
11.
The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia
by Kokkola, A.
Alimentary pharmacology & therapeutics, 2002, Vol.16 (3), p.515-520
12.
Three cases of cardiac complications associated with Campylobacter jejuni infection and review of the literature
by HANNU, T
European journal of clinical microbiology & infectious diseases, 2005, Vol.24 (9), p.619-622
13.
Inflammation and intestinal metaplasia at the squamocolumnar junction in young patients with or without Helicobacter pylori infection
by Oksanen, A
Gut, 2003, Vol.52 (2), p.194-198
14.
First‐line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens
by Koivisto, T. T.
Alimentary pharmacology & therapeutics, 2005, Vol.21 (6), p.773-782
15.
Genetic and Environmental Factors in the Immunopathogenesis of Atopy: Interaction of Helicobacter pylori Infection and IL4 Genetics
by Pessi, T
International Archives of Allergy and Immunology, 2005, Vol.137 (4), p.282-288
16.
Incidence of Helicobacter pylori strains activating neutrophils in patients with peptic ulcer disease
by Rautelin, H
Gut, 1993, Vol.34 (5), p.599-603
17.
High frequency of helicobacter negative gastritis in patients with Crohn's disease
by Halme, L
Gut, 1996, Vol.38 (3), p.379-383
18.
Inflammation and cytokeratin 7/20 staining of cardiac mucosa in young patients with and without Helicobacter pylori infection
by Oksanen, A
Journal of clinical pathology, 2005, Vol.58 (4), p.376-381
19.
Strain and host characteristics of Campylobacter jejuni infections in Finland
by Schönberg-Norio, D
Clinical microbiology and infection, 2006, Vol.12 (8), p.754-760
20.
Composition of human faecal microbiota in resistance to Campylobacter infection: Bacteriology
by Kampmann, C
Clinical microbiology and infection, 2016, Vol.22 (1), p.61.e1-61.e8
